NovaBridge Biosciences (NBP) Other Non Operating Income (2019 - 2025)

NovaBridge Biosciences (NBP) has reported Other Non Operating Income for 5 consecutive years, with -$1.8 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Other Non Operating Income fell 630.3% year-over-year to -$1.8 million; the TTM figure through Dec 2025 stood at -$1.7 million (up 64.35% YoY), while the FY2025 annual figure was -$1.7 million, up 64.35% from the prior year.
• Other Non Operating Income declined to -$1.8 million in Q4 2025 per NBP's latest filing, from $14000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $6.1 million in Q2 2024 and bottomed at -$16.4 million in Q2 2023.
• Historically, Other Non Operating Income has averaged -$1.8 million across 3 years, with a median of $14000.0 in 2025.
• On a YoY basis, Other Non Operating Income climbed as much as 141.57% in 2025 and fell as far as 630.3% in 2025.
• NovaBridge Biosciences' Other Non Operating Income stood at $1.0 million in 2023, then tumbled by 67.39% to $330000.0 in 2024, then tumbled by 630.3% to -$1.8 million in 2025.
• Business Quant data shows NBP's Other Non Operating Income at -$1.8 million in Q4 2025, $14000.0 in Q3 2025, and -$190000.0 in Q2 2025.